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ABSTRACT
The Cost Effectiveness of Psychotherapy for Treating
Adults with Post-Traumatic Stress Disorder
Micah LaVar Ingalls
School of Family Life, BYU
Master of Science
This paper presents results from cost-analysis research for treating Post-Traumatic Stress
Disorder in adults. Data for this research was provided by Cigna, a nation-wide healthcare
manager in the United States of America. The sample size was 12,845 adults who were
diagnosed with PTSD and received outpatient individual and family psychotherapy from one of
the following mental health care providers: Marriage and Family Therapists (MFTs), Master’s
Nurses (RNs), Medical Doctors (MDs), Professional Counselors (LPCs), Psychologists (PSYs),
and Social Workers (MSWs). Results were compared across treatment modality, across
practitioner license type and between practitioner educational levels. The results demonstrated
that family therapy was most cost effective and used the fewest sessions, while mixed therapy
was least cost effective. Among practitioner licensure types MDs were found to be the most cost
effective, while the group of RNs, MSWs and MFTs were least cost effective compared to one
another. Also, no significant differences in cost effective treatment outcomes were found
between Masters Level and Doctoral Level practitioners.

Keywords: cost effectiveness, cost, post-traumatic stress disorder, ptsd, psychotherapy, family
therapy
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Introduction
Post-Traumatic Stress Disorder (PTSD) is associated with significant psychological,
physical, and relational burdens (Greenman & Johnson, 2012; APA, 2013; Gallagher and
Ressick; 2013). The changes that individuals and families experience with PTSD can result in a
variety of individual and relational distresses (Gorman, Fitzgerald & Blow, 2009; Boss, 2010).
Research continues to bring to light better understanding about mental health disorders, their
symptoms, and best practice techniques. This study adds to the mental health field by conducting
a comparative cost analysis which considers the cost effectiveness of treating Post-Traumatic
Stress Disorder (PTSD) among adults.
Lifetime prevalence rates of PTSD for the general public are between 6% and 9%
(Pacella, Hruska, & Delahanty, 2013), with the DSM-V claiming lifetime prevalence rates for a
75 year lifespan at 8.7% (APA, 2013). Individuals diagnosed with PTSD often experience a
broad range of biopsychosocial problems (Reynolds, 2007; Monson et al., 2012; Bryant &
Friedman, 2001; Coulter, 2013) such as relational distress, a heightened startle response,
nightmares, flashbacks, increases in fear, and demands for control in life, along with many other
changes. Furthermore, adults diagnosed with PTSD also have a high comorbidity with
depression and a strong correlation with suicide (APA, 2013; Davis, Witte & Weathers, 2014;
Ramsaw et al. 2014). The general symptoms of PTSD combined with the trauma, in addition
with a correlation with other biopsychosocial responses, provides a compelling argument for the
study of a variety of treatment modalities to find the most cost effective treatment for PTSD and
its associated symptoms.
Moreover, the far reaching effects of PTSD are felt by the individual who is suffering
from trauma related symptoms, by their family, by their associates as well as by their society
1
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(Kilmer et al., 2011; Coulter, 2013). These effects are felt emotionally, relationally and
financially. Therefore, conducting a comparative cost effectiveness analysis of various factors
that influence treatment outcome is beneficial to individuals, families, and society (Basham,
2008; Crane & Payne, 2011). The research reported in the current study compares the cost
effectiveness of treating PTSD across treatment modalities (individual, family, and mixed
psychotherapy); across practitioner licensure type (Marriage and Family Therapists (MFTs),
Master’s Nurses (RNs), Medical Doctors (MDs), Professional Counselors (LPCs), Psychologists
(PSYs), and Social Workers (MSWs)); between types of treatment approaches (biomedically
oriented vs. talk therapy oriented); and between education and the associated differences in
payment rates for masters vs. doctoral level practitioners. Comparing across practitioner type
will allow for the analysis of the cost of therapeutic services provided to clients. The costs of
therapy are examined and compared in terms of cost effectiveness, client drop out, and client
recidivism. The results of this data provides policy makers with information to assist them in
their efforts to provide cost effective treatments for individuals, families, and societies suffering
from the effects of PTSD (Mills, 2012; Forneris et al., 2013; Crane & Payne, 2011; Law &
Crane, 2000).
Literature Review
Post-Traumatic Stress Disorder
Post-Traumatic Stress Disorder involves exposure to or experiencing an event that
resulted in the individual experiencing intense fear, helplessness, or horror. This could occur
from experiencing or witnessing combat trauma, violent assaults, sexual assaults, car accidents,
natural disasters or any other form of trauma. As a result, individuals may have symptoms such

2
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as re-experiencing the event, distressing dreams, feeling as if the event were recurring intense
psychological distress, or strong physiological responses to external stimuli (APA, 2013).
Research shows that lifetime prevalence rates of PTSD range from 6-9% for the general
population and about 17% for military combat populations —U.S. Army soldiers and Marines
assessed during the time of deployment in Iraq (Sundin, Fear, Iversen, Rona, & Wessely, 2010).
Since PTSD is two to three times higher in military combat populations, they can be a good
sample for medical cost offset research. An example of the potential cost offset effect for trauma
treatment is demonstrated by Foreneris et al. (2013). They estimated that if all U.S. military
personnel received evidence based care (that is care that is proven to reduce symptoms) the total
treatment expenditure for treating trauma and depression among military combat veterans could
be reduced by as much as $1.7 billion over a two year treatment period (Forneris et al., 2013).
Even though ideal treatment will not always occur, Forneris et al.’s (2013) results suggest the
potential monetary value of psychotherapy treatment of PTSD.PTSD is a growing problem
among combat veterans and is often comorbid with other mental health issues (Chan, Cheadle,
Reiber, Unützer, & Chaney, 2009). Based on Chan et al.’s (2009) study, individuals diagnosed
with PTSD had higher utilization of health care. They also reported that over a one year period
individuals with both PTSD and depression had much higher outpatient costs ($1,399 more than
those with just depression) and medical care costs ($425 more than those with just depression)
than those individuals with depression and no PTSD. Such research continues to reveal the
complexity of PTSD and its associated cost of treatment.
Psychological and physical symptoms associated with PTSD. The influence of PTSD
also has a significant impact on individual’s well-being (Bryant & Friedman, 2001; Pacella, et
al., 2013). For example, the APA (2013) reports that PTSD sufferers often experience
3
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psychological distress, such as re-experiencing, avoidance, numbing, and hyper arousal. Also,
Gallagher and Ressick (2013) report positive associations between PTSD and cognitions of
hopelessness. Moreover, hopelessness cognitions are highly correlated with suicide and suicidal
ideation (Jakupack et al., 2011). In comparison to the general population, it is estimated that
1.1%-4.6% of people attempt suicide at some point in their lifetime, while approximately 9.6%
of those diagnosed with PTSD have attempted suicide since the trauma (Tarrier & Gregg, 2004).
Furthermore, individuals with PTSD of experience comorbid mental and physical health
challenges including substance abuse, depression, anxiety, later life dementia, musculoskeletal
pain, cardio-respiratory, gastrointestinal issues and general health complaints ( APA, 2013;
Ramsaw et al., 2014; Barret et al., 2002; Pacella et al., 2013).
Impact of PTSD on family relationships. Research with individuals suffering from
PTSD also demonstrates the socially and relationally debilitating nature of PTSD (Gallagher &
Ressick, 2012; Monson et al., 2012). Within partner relationships, PTSD correlates with
relationship distress, relationship aggression, caregiver burden, psychological distress (Monson
et al., 2012), and relationship sexual satisfaction (McFarlene & Bookless, 2001). Further,
McFarlene and Bookless (2001) also reported that experiencing trauma was associated with
increased irritability, increased withdrawal, and increased avoidance of discussions, which had
detrimental effects on self-awareness, intimacy, sexuality, and communication. These areas are
all vital aspects of functional relationships (McFarlene & Bookless, 2001) that may be damaged
or altered by PTSD. In a meta-analysis by Taft, Watkins, Stafford, Strees, Monson (2011)
reported correlations between PTSD and intimate relationship discord, intimate relationship
physical aggression, and intimate relationship psychological aggression. Consequently, not only
is the identified patient impacted by PTSD but often their intimate partner experiences secondary
4
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trauma or compassion fatigue (Goff et al., 2005). The general idea is that those who are close
with a trauma survivor often pick up many PTSD like symptoms (Goff et al., 2005). Thus, it
would be prudent to address these relational changes along with the treatment of trauma
symptoms when treating PTSD in adults.
In terms of parent child relationships, parents with PTSD also suffer disruptions in their
relationships with their children (Gorman, Fitzgerald & Blow, 2009). Gorman et al. (2009)
demonstrated that parental PTSD had both direct and indirect effects on family functioning and
the development of young children. These detrimental effects included personalization of
parent’s anger or rejection, declines in affective expressions by the parent, confusion about
“ambiguous loss”, and loss of parental support and connection (Gorman et al., 2009; Boss,
2010). One type of ambiguous loss is when a family member is still physically present, but they
have changed. Thus leaving the family experiencing a loss for who the person used to be, but
also confused about how to mourn that loss and adjust to the change since the individual is still
present. This results in an ambiguous loss, which as defined by Boss, (2010) is an unclear,
traumatic loss which affects ones relationships. When ambiguous loss is experienced it can
distress and even traumatize families (Boss, 2010). Furthermore, McFarlene and Bookless’
(2001) report that those who have experienced trauma have correlated increases in irritability,
increases in withdrawing and increases in avoidance of discussions. Such responses to trauma
could leave the child feeling distant from their parent. Also, children may have a harder time
adjusting to the fact that their parent is different than they were prior to the trauma. Therefore,
treating PTSD within families appears to have promise for alleviating the problems of family life
associated with PTSD.

5
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Cost Effectiveness
Cost effectiveness research provides a method that allows for the comparison of
treatment outcomes in economic terms (Law & Crane, 2000; Crane & Payne, 2011; Crane &
Christenson, 2012). One type of cost effectiveness research that has been used to support the use
of psychotherapy services is the concept of “medical cost offset,” which is defined by Anderson
and Estee (2002) as the net change in medical care costs in association with the net change in
mental health care costs (Anderson & Estee, 2002). Medical cost offset research laid the
foundation for other types of cost effectiveness research. Other types of cost effectiveness
research include the cost effectiveness of various treatment modalities, the cost effectiveness of
differing practitioner license types, the impact of diagnosis on the costs of therapy, and the
varying costs of psychotherapy by gender (Crane & Payne, 2011; Crane et al., 2012;
Christenson, Crane, Bell, Beer & Hillin, 2014; Fawcett & Crane, 2013). These types of cost
effectiveness research have already provided many valuable contributions to the field of
psychotherapy (Husereau et al., 2013). These contributions, which are discussed in later
sections, help establish the value of various types of treatment and the cost effectiveness of select
treatment providers.
Dropout and recidivism as measures of cost effectiveness. Recent studies demonstrate
that cost effectiveness research allows for the comparison of treatment outcomes across various
treatment variables (Law & Crane, 2000; Crane & Payne, 2011; Crane & Christenson, 2012).
Two key aspects of treatment that factor into treatment cost effectiveness are client dropout rates
and client recidivism rates (Law & Crane, 2000; Crane & Payne, 2011; Crane & Christenson,
2012). Ehlers et al. (2013) cited nearly a dozen studies that claimed that dropout rates for
individual psychotherapy treatment of PTSD ranged anywhere from 26%-43%. That means that
6
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anywhere from a quarter to almost one half of PTSD clients do not complete treatment, with
many of them not returning after the first session. Client dropout is influenced by client
demographic factors, pre-treatment symptom severity, and feelings of shame, anger, or guilt
(Mills, 2012). Furthermore, it has been observed that symptoms have a tendency to peak most
commonly between the assessment intake and the beginning of therapy (Ehlers et al., 2013).
This rapid spike in symptoms may potentially be correlated to the high dropout rate which occurs
during this time period of therapy.
Much of the research that has been conducted in regards to PTSD evaluates and compares
different models of treatment (Levi, 2013). Although this analysis is valuable, most research for
PTSD demonstrates that there is no significant difference in treatment outcomes across different
theoretical models (Gallagher & Ressick, 2012). With the theoretical stalemate for symptom
management, it becomes valuable to consider other aspects that may increase or decrease the
cost effectiveness of PTSD treatment such as treatment modality, practitioner license, and client
gender. Thus, with the growing literature on various treatments for PTSD it now becomes vital
to consider not only the effectiveness but also the cost effectiveness of these treatments in order
to determine which treatments to consider administering to individuals suffering from PTSD
(Freed et al., 2009; Mills, 2013).
The impact of treatment modality on cost effectiveness. Comparative, cost
effectiveness research provides a measure that can be used for comparison between
psychotherapy treatment modalities (individual, family, and mixed) (Crane & Christenson, 2012;
Crane & Payne, 2011). Results from previous studies demonstrate differences in treatment
outcomes based upon the type of treatment modality the patient received (Crane & Payne, 2011;
Crane et al., 2013). In general, it has been found that family therapy is more cost effective than
7
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individual therapy, or a mixed modality of therapy (Crane & Payne, 2011). However there are
sometimes differences in treatment modality cost effectiveness depending on the specific
diagnosis. For example, when considering sexual dysfunction, it was found that a mixed therapy
modality was more cost effective (Fawcett & Crane, 2012). Whereas recidivism rates for
relational problems were not significantly different based upon treatment modality (Moore &
Crane, 2014). Furthermore, it was reported that family therapy had more cost effective outcomes
than individual therapy modality or mixed therapy modality when treating depression and
substance use (Crane et al., 2013; Morgan, Crane, Moore & Eggett, 2013).
Individuals diagnosed with PTSD often face additional mental health struggles and
physical health struggles in conjunction with their PTSD. For example depression, anxiety and
substance abuse are often comorbid with PTSD (APA, 2013; Ramsaw et al. 2014). As
previously discussed, the treatment modality used to treat depression and substance abuse
impacts the cost effectiveness of the treatment. Declines in physical health are also correlated
with diagnoses of PTSD (Barrett et al., 2002; Pacella et al., 2013). In particular, physical health
distress may include increased musculoskeletal pain, increased cardio-respiratory symptoms,
increased gastrointestinal issues, and general health complaints (Pacella et al., 2013). Therefore,
the correlation between PTSD and mental and physical health declines may also impact cost
effectiveness.
The Impact of Practitioner License on Cost Effectiveness.
Practitioner license type has also yielded unique results in terms of cost effective
treatment outcomes (Crane & Payne 2011; Crane et al., 2012; Crane & Christenson, 2012). For
example, when comparing provider licensure type (Marriage and Family Therapists (MFTs),
Master’s Nurses (RNs), Medical Doctors (MDs), Professional Counselors (LPCs), PSYs, and
8
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Social Workers (MSWs)), Moore, Hamilton, Crane & Fawcett (2011) found that practitioners
with the MFT license were more cost effective than RNs, MDs, and PSYs but were less cost
effective than MSWs and LPCs.
Furthermore, practitioner license impact on cost effectiveness has been compared across
a variety of different diagnoses (Crane & Payne, 2011; Crane & Christenson, 2012). For
example, when considering Somatoform Disorder no significant differences were found in
treatment outcomes across professional licensure (Crane et al., 2012). Whereas, MFT’s were
found to be the most cost effective when treating depression (Crane et al., 2012). Furthermore,
when considering substance abuse disorders MFT’s were found to have the lowest recidivism
rate. Therefore, this study considers the impact of practitioner license type on the cost
effectiveness of treating PTSD.
Cost effectiveness of mental health treatments is measured through analysis of treatment
efficacy compared on the scale of clinical outcome per unit of cost (Crane et al., 2013). This
provides a unique and valuable measurement guideline that allows for cross-disciplinary
comparison, and treatment modality comparisons. Furthermore, health care cost effectiveness
analysis research influences decisions made by insurance companies, government officials,
practitioners, health care utilizers, and others. Therefore, the cost effectiveness research
implications provide strong support for conducting accurate and extensive research in this area of
study.
Treatment Modalities for Post-Traumatic Stress Disorder
There are a number of differing treatments for PTSD (Bryant & Friedman, 2001; Allen &
Bloom, 1994); including biomedical treatments, peer to peer support groups, individual, family,
group and a mixed therapy modality. Ehlers et al. (2013) recommend that trauma focused
9

Running head: Cost-effectiveness of Treating Post-Traumatic Stress Disorder
psychological treatment be used as a first-line of treatment for PTSD. The scope of this research
is the comparison of treatment outcomes across treatment modalities and across practitioner
training as evidenced by mental health license types.
Biomedical treatments. Medications for PTSD can be used to aid individuals with their
biological symptoms of PTSD along with their psychological symptoms. A meta-analysis of
medical treatment efficacy was published in the International Journal of
Neuropsychopharmacologicum in 2012 by Ipser and Stein. According the authors, selective
serotonin reuptake inhibitors are the medication of choice within the field (Ipser &Stein, 2012).
Furthermore Ipser and Stein’s (2012) Meta-analysis reported some promising findings for
selective noradrenergic reuptake inhibitors and found lacking evidence of effectiveness for
bensodiazepines. In a recent study by Greer, Grob and Halberstadt (2014) medical Cannabis has
been investigated as an alternative treatment for the symptoms of PTSD. It is recommended that
along with medications, individuals also seek out psychotherapy. Oehen, Traber, Widmer and
Schnyder (2013) ran a clinical trial that tested the effectiveness of combining MDMA
(Methylenedioxymethamphetamine) with psychotherapy treatment for PTSD. They found that
there were clinically and statistically significant self-reported positive changes in client
Posttraumatic Diagnostic Scale scores (Oehen et al., 2013).
Individual psychotherapy. When PTSD is treated with individual psychotherapy, it has
been found to be more effective than no treatment (a waitlist control group) in the reduction of
PTSD symptoms (Bryant & Friedman, 2001). In the Bryant and Friedman (2001) research, all
clients who had been waitlisted still had PTSD symptoms at the end of the 5 week waitlist
period, whereas 65%-68% of clients who were in individual treatment showed improvement.

10
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Another form of individual psychotherapy is seen in peer to peer support groups. In these
groups, peers who are others who have experienced similar trauma, work in a mentor-mentee
type role. In one report of National Guard soldiers, peer to peer based groups were reported as
being effective in reinforcing the general bond of combat groups, minimizing the stigma of a
mental illness, and increased treatment with these groups (Pfeiffer et al., 2012).
Family psychotherapy. Family psychotherapy has the potential to be effective in
treating PTSD (Coulter, 2013). When one individual in the family is suffering from PTSD the
family frequently is impacted and often can be a moderating influence of the impact of PTSD on
the identified patient (Matsakis, 2013). Since PTSD has been cited as having detrimental
impacts on family relations (McFarlene & Bookless, 2001; Taft et al., 2011; Monson et al., 2012)
it may be valuable to treat PTSD with family psychotherapy. For example, Elhers et al. (2013)
report that individuals with PTSD who were not currently living with or had never lived with a
partner had worse therapy outcomes. Therefore, having close social support is implied by Elhers
et al. (2013) to have a moderating influence on PTSD therapy outcomes. Elhers et al. (2013)
research helps lay the groundwork for studying the value of including the individual’s social
support network in the treatment of PTSD through family psychotherapy (Coulter, 2013;
Matsakis, 2013).
There is little literature discussing clinical effectiveness in treating adults with PTSD
through a systemic or family-based model (Coulter, 2013; Jordan, 2011; Goff & Smith, 2005).
Instead, the majority of the research in this area discusses the impact of PTSD on the family
system. For example Basham (2008) discusses the attachment injuries that may occur from
trauma. There are ample amounts of theoretical conjecture that suggest that treating PTSD
through a family model would be effective because of the increased family support and social
11
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structure (Zulueta, 2006). Furthermore, Brewin, Andrews & Valentine (2000) reviewed eleven
studies that correlated the lack of social support with PTSD symptoms and found the effect size
was .40, the largest of any risk factor they evaluated. Greenman and Johnson (2012) reported the
emotionally focused therapy for couples has been found to be effective in reducing PTSD
symptoms. In particular, women who had experienced childhood abuse from family member(s)
reported notable reductions in trauma symptoms after 20 sessions of couples EFT (Greenman &
Johnson, 2012). Although, these are preliminary studies, they support the theory that increased
social support can help reduce PTSD symptoms.
Mixed psychotherapy. A mixed modality of treating PTSD combines both individual
and family psychotherapy as a treatment approach (Crane & Payne, 2011). There is a gap in the
research of looking at the treatment outcomes of treating PTSD with a mixed therapy modality.
Using a mixed modality of treatment has been found to be cost-effective when conducting sex
therapy to treat sexual dysfunctions (Fawcett & Crane, 2013). Although this has yet to be tested
for PTSD, applying a mixed method of treatment for PTSD may allow the client to receive the
best of both treatment modalities. For example, the client may be able to explore the deep
trauma in individual sessions to avoid compassion fatigue for family members, while also
receiving the social support and strength that conjoint therapy offers. Conversely, mixed
psychotherapy may result in a disjointed feel to therapy. There may be a disconnect between
family sessions and individual sessions which may add to client frustration and suffering.
Therefore, further research would provide valuable information regarding the effectiveness of
mixed psychotherapy.

12
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Gender as a Unique Factor of PTSD
Although men and women are exposed to roughly the same number of traumatic events,
women are twice as likely to develop PTSD (Tolin & Foa, 2002). This disparity in PTSD
diagnoses between genders suggests that trauma impacts men and women differently. It has
been suggested that one possibility for the higher prevalence among women is due to
interpersonal assaultive violence rates which are higher among women. However, when
researchers Hetzel-Riggin and Roby (2013) controlled for assaults, women were still found to
have a higher prevalence of PTSD. Since PTSD diagnoses are more common among women, it
would be valuable to consider if gender impacts PTSD treatment outcomes.
Current Study
The value of the present study is that it differentiates between psychotherapy modalities
in the cost effectiveness of the treatment provided for PTSD. Furthermore, this study identifies
differences in cost effectiveness by license type. The results of this study provide valuable
empirically supported research to the general public, to mental health professionals, to policy
makers, insurance companies, to healthcare providers, and to those who suffer from PTSD. The
empirically supported data of this study obtained from a large sample size helps to better inform
each of the preceding entities on the ways in which cost effective treatments can be provided to
individuals who are suffering from PTSD. Finally, the results of this study add to the research
base that can inform the mental health care community of a few cost effective methods for
providing care to those suffering with PTSD.
Research Questions
1. What is the average total cost and average cost effectiveness of treating Post-Traumatic
Stress Disorder (PTSD) with psychotherapy?
13
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2. What are the differences in treatment outcomes (total cost, number of sessions, cost
effectiveness, dropout, and recidivism), when comparing treatment modality (individual
therapy, family therapy, and mixed therapy) for treating individuals diagnosed with
PTSD?
3. What are the differences in treatment outcomes (cost effectiveness, dropout, recidivism,
number of sessions, and total cost) when comparing treatments provided by practitioners
of differing license types (MFTs, RNs, MDs, LPCs, PSYs, MSWs) for treating clients
diagnosed with PTSD?
4. What are the differences in treatment outcomes (cost effectiveness, dropout, recidivism,
number of sessions, and total cost) when comparing treatments provided by biomedical
practitioners (Master’s Nurses and Medical Doctors) with treatments provided by talk
therapists (MFTs, LPCs, PSYs, and MSWs )?
5. What are the differences in treatment outcomes (cost effectiveness, dropout, recidivism,
number of sessions, and total cost) when comparing treatments provided by Masters level
practitioners compared with doctorate level practitioners?
6. What are the differences in outcomes in PTSD treatment by gender?
Method
Design
This research uses a comparative, retrospective analysis of insurance claims from Cigna,
a nationwide health insurance management company in the United States. The dataset for this
research was extracted from over 5 million insurance claims between the years of 2001 and
2006. Based upon the 1996 Health Insurance Portability and Accountability Act (HIPAA), nonidentifiable administrative data may be used for comparative statistical analysis. No personal
14
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client or provider information is present in the data. The data set contains the following 11
variables: 1. A client identification number unique for each client; 2. The age and gender of the
client; 3. The treatment date; 4. The state where the visit took place; 5. The current procedural
terminology (CPT) code; 6. The primary DSM-IV diagnosis; 7. The therapist’s license type; 8.
The highest degree earned by the therapist; 9. The dollar amount of the claim; 10. The number of
sessions or visits per claim; and 11. A calculated cost-effectiveness measure (Crane & Payne,
2011). For a more detailed explanation of the original dataset and the extraction process see the
Crane and Payne (2011) article.
Criteria for PTSD Diagnosis.
The criteria for a PTSD diagnosis used here are based upon the DSM IV-TR criteria which were
used during the period of data collection.
According to the APA (2000) “The essential feature of Posttraumatic Stress
Disorder is the development of the characteristic symptoms following exposure to
an extreme traumatic stressor involving direct personal experience of an event
that involves actual or threatened death or serious injury, or other threat to one’s
physical integrity; or witnessing an event that involves death, injury or a threat to
the physical integrity of another person; or learning about unexpected or violent
death, serious harm, or threat of death or injury experienced by a family member
or other close associate. The characteristic symptoms resulting from the exposure
to the extreme trauma include persistent re-experiencing of the traumatic event,
persistent avoidance of stimuli associated with the trauma and numbing of general
responsiveness, and persistent symptoms of increased arousal.” (P. 424)
These diagnostic criteria are the standards that clinicians use for PTSD diagnosis
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Sample
The sample size (n=12,845) is made up of adults (ages 18-82) diagnosed with PTSD
(DSM IV Code 309.81) who received individual, family, or mixed therapy (a derived modality
that combines both mixed and individual therapy). These 12,845 cases were pulled from a data
set made up of 6 million insurance claims (and over 500,000 unique individuals) provided by
Cigna, a health insurance benefits administration system. Only individuals who were 18 years of
age at the start of treatment and who had PTSD (ICD9 Code 309.81) as their primary diagnosis
were included in the sample of 12,845 cases. Of these participants 76.5% (9,823) are female,
23.4% (3,000) are male, and 0.1% (22) did not have gender recorded within the data set.
Considering that more than 75% of the sample are female it would be valuable to consider if
there are differences in treatment outcomes by gender. Regionally, all 50 states within the U.S.
were represented within the data. No other descriptive statistics were available.
Providers
This study examines the cost effectiveness of mental health services provided by six
professional license types. These license types are MFTs, RNs, MDs, LPCs, PSYs, MSWs.
These service providers were included in the study due to their national recognition as
independently licensed health care practitioners (Crane & Payne, 2011). In instances when a
provider had multiple licenses, the provider was categorized based upon the license identified as
the primary license.
Definition of Terms and Measures
Episode of care. Episode of care (EoC) is defined by Cigna as a sequence of continuous
treatment for the same patient. An EoC begins with the first psychotherapy session and ends 90
days after the last psychotherapy session.
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Recidivism. For the purposes of this study, recidivism is defined as a patient returning to
therapy (after at least a 90 day break) for an additional episode of care with the same provider
type (Crane & Payne, 2011; Fawcett & Crane, 2013).
Total cost. Total cost is defined as the total dollar amount paid by Cigna for all therapy
services during the episode of care.
Cost effectiveness. The cost effectiveness formula was developed based upon the data
available in the insurance claims provided by Cigna. The formula for cost effectiveness is:
Estimated cost effectiveness = 1st EoC average cost + (1st EoC average cost * recidivism rate)
(Crane & Christenson, 2008; Crane & Payne, 2011; Moore, Hamilton, Crane & Fawcett, 2011).
This formula was developed to compare different types of therapy treatments and professions
based on treatment cost and recidivism rate. Participants who dropped out of treatment were
eliminated from cost effectiveness analysis to prevent artificially low costs and recidivism rates.
The development and use of this formula has been effective in providing primary results of cost
effectiveness analysis and comparison research (Crane, 2008; Crane & Payne, 2011; Moore et
al., 2011).
Drop out. Drop out is defined as a participant attending only one session of therapy for
individual treatment or family treatment and for mixed modality one session of family therapy
and one session of individual therapy and then not returning for future services.
Provider type. Provider type is considered the license type in which the therapist is
legally licensed and was listed first on the insurance claim form MFTs, RNs, MDs, LPCs, PSYs,
and MSWs.
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Modality. Modality is defined as the therapeutic context within which mental health
services were provided. This could be family therapy, individual therapy or a combination of the
two modalities creating a third type known as mixed therapy.
Family therapy. Family therapy is identified in this study by Current Procedural
Terminology (CPT) code 90847, “Family psychotherapy (conjoint psychotherapy) (with patient
present)” (American Medical Association, 2006, p. 278).
Individual therapy. Individual therapy in this study is identified by CPT code 90806,
“an insight oriented, behavior modifying, and/or supportive treatment in an office or outpatient
facility, approximately 45 to 50 minutes face-to-face with the patient” (American Medical
Association, 2006, p. 277).
Mixed therapy. Mixed therapy in this study is defined as an EoC including sessions of at
least one session of both family and individual therapy.
Research Questions Analysis
1. What is the average total cost and average cost effectiveness of treating PTSD with
psychotherapy?
a. Descriptive statistics were used to demonstrate average total cost and cost
effectiveness of treating PTSD with psychotherapy
2. What are the differences in treatment outcomes (total cost, number of sessions, cost
effectiveness, dropout, and recidivism), when comparing treatment modality for treating
individuals diagnosed with PTSD?
a. ANOVA was used to compare treatment modalities for the dependent variables of
cost effectiveness, number of sessions, and total cost. A post hoc Tukey test was
used for pairwise comparison. Also logistical regression was used to compare
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treatment modalities for the dependent categorical variables of dropout and
recidivism
3. What are the differences in treatment outcomes, when comparing treatments provided by
practitioners of differing license types for treating clients diagnosed with PTSD?
a. An ANCOVA (with fee per session as the covariate) was used to compare
practitioner license types for the dependent variables of cost effectiveness,
number of sessions, and total cost. Pairwise comparisons were used to analyze
how each license compared with each other. Also logistical regression was used
to compare practitioner license types for the dependent categorical variables of
dropout and recidivism.
4. What are the differences in treatment outcomes when comparing treatments provided by
biomedical practitioners (RNs and MDs) with treatments provided by talk therapists
(MFTs, LPCs, PSYs, and MSWs)?
a. An ANCOVA (with fee per session as the covariate) was used to compare
practitioner license types for the dependent variables of cost effectiveness,
number of sessions, and total cost. Also logistical regression was used to
compare practitioner license types for the dependent categorical variables of
dropout and recidivism.
5. What are the differences in treatment outcomes when comparing treatments provided by
Masters level practitioners compared with doctorate level practitioners?
a. An ANCOVA (with fee per session as the covariate) was used to compare
practitioner license types for the dependent variables of cost effectiveness,
number of sessions, and total cost. Also logistical regression was used to compare
19

Running head: Cost-effectiveness of Treating Post-Traumatic Stress Disorder
practitioner license types for the dependent categorical variables of dropout and
recidivism.
6. What are the differences in outcomes in PTSD treatment by gender?
a. An ANOVA was used to compare practitioner license types for the dependent
variables of cost effectiveness, number of sessions, and total cost. Also logistical
regression was used to compare practitioner license types for the dependent
categorical variables of dropout and recidivism
Results
Research question one asked, “What are the average total cost and average cost
effectiveness of treating PTSD with psychotherapy?” The average total cost of treatment for
PTSD across all health care providers and across all modality types is $570.88 (SD=883.99).
While the cost-effectiveness average is $838.05 (SD=1506.63). See Table 1.
The second question examined “What are the differences in treatment outcomes when
comparing treatment modality (individual therapy, family therapy, and mixed therapy) for
treating individuals diagnosed with PTSD?” Using one-way ANOVA, significant differences
were found between modalities for average number of sessions [F (2, 12842) = 151.60, p<
0.001], average cost [F (2, 12842) = 205.09, p< 0.001], and average level of cost effectiveness [F
(2, 12842) = 154.63, p< 0.001]. Post hoc Tukey test revealed that in each of the types of
outcomes, family therapy was the lowest, followed by individual therapy, and then mixed
therapy was the highest (see Table 2). Furthermore, individual therapy recidivism and dropout
rates are also reported in Table 2. Interestingly enough, the dropout rates for individual (24%),
family (36%), and mixed (4%) therapies are within or below Elhers et al. (2013) reported
average range (26%-43%) of individuals with PTSD who dropout.
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Furthermore, logistic regression was used to compare therapy modalities on recidivism
(see Table 3). Family therapy served as the reference group, so results were obtained for
individual therapy versus family therapy and mixed modality versus family therapy. Participants
were more likely to recidivate if they had individual therapy than if they had family therapy (B =
1.109, SE= .138, p < .001). These results indicate that those receiving individual therapy were
roughly 203 times more likely to recidivate than those receiving family therapy alone
(exp[1.109]=3.032). Similarly, participants in mixed modality therapy were more likely to
recidivate than those in family therapy (B = 2.139, S.E. = .146, p< .001). Those in mixed
modality therapy were 749 times more likely to recidivate than those who received family
therapy alone (exp[2.139]=8.49).
Logistic regression was also used to compare therapy modalities in dropout (See Table
3). Family therapy served as the reference group. Participants were more likely to drop out if
they had family therapy exclusively than if they had individual therapy exclusively (B = -.566,
SE= .089, p < .001). These results indicate that those receiving family therapy were 74 times
more likely to drop out as those receiving Individual therapy (exp[-.566]=.568). Similarly,
participants who received family therapy were also more likely to drop out than those in a mixed
therapy modality (B = -2.684, S.E. = .163, p< .001). Those in family therapy were 1,328 times
less likely to dropout than those in mixed therapy (exp[-2.684]=.068).
The third question asked “What are the differences in treatment outcomes when
comparing treatments provided by practitioners of differing license types for treating PTSD?”
ANCOVA was used to compare first episode of care total cost, cost effectiveness and total
session across practitioner licensure type while controlling for fee per session. As shown in table
4 an ANCOVA [between-subjects factor: practitioner license type; Covariate: fee per session]
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revealed significant main effects of practitioner license for average total cost [F (5, 11,909) =
4.974, p < 0.001], for average total number of sessions [F (5, 11,909) = 3.678, p = 0.03], and for
average level of cost effectiveness [F (5, 11,909) = 4.902, p < 0.001]. See Tables 5, 6, and 7 for
significant between factor differences. When controlling for fee per session, MDs were found to
use fewer sessions, cost less, and were more cost effective than all other practitioners treating
PTSD.
As seen in table 8, logistic regression was used to compare recidivism and dropout by
practitioner license. MFTs served as the reference group so results were obtained for RNs, MDs,
LPCs, PSYs, and MSWs as compared to MFTs. For recidivism, individuals were more likely to
recidivate if they received care from RNs than if they received care from MFTs (B = .598, SE =
.182, p = .001). These results indicate that those receiving care from RNs are about 82 times
more likely to recidivate as those who received care from MFTs (exp[.598] = 1.819). Also,
persons were more likely to recidivate if they received care from MSWs than if they received
care from MFTs (B = .254, SE = .082, p = .002). These results indicate that those receiving care
from MSWs are about 29 times more likely to recidivate than those who received care from
MFTs (exp[.254] = 1.289). Similarly, individuals were more likely to recidivate if they received
care from PSYs than if they received care from MFTs (B = .251, SE = .085, p = .003). These
results indicate that those receiving care from Psychologist are also about 29 times as likely to
recidivate as those who received care from MFTs (exp[.251] = 1.285). Whereas, there was no
difference in likelihood to recidivate between MDs and MFTs (B = .194, SE = .187, p = .299)
and between LPCs and MFTs (B = .124, SE = .087, p= .154)
Logistic regression was also used for drop out (see Table 8), individuals were more likely
to drop out if they received care from MDs than if they received care from MFTs (B= .946, SE =
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.172, p < .001). These results indicate that those receiving care from MDs are about 156 times
more likely to drop out than those receiving care from MFTs (exp[.946] = 2.575). However,
Table 8 also demonstrates that individuals were equally as likely to drop out if the received care
from LPCs (B= .119, SE = .089, p = .180), RNs (B= -.004, SE = .206, p = .983), MSWs (B= .023, SE = .085, p = .783), or PSYs (B= -.033, SE = .088, p = .707) as those who received care
from MFTs.
Research question four asked “What are the differences in treatment outcomes comparing
treatments provided by biomedical practitioners vs. treatments provided by “talk therapists?” As
shown in Table 9 an ANCOVA was used to compare the treatment outcomes of total dollars [F
(1, 11,913) = 6.03, p = 0.014], total number of sessions [F (1, 11,913) = 2.50, p = 0.114], and
cost effectiveness [F (1, 11,913) = 5.79, p = 0.016], while controlling for fee per session. On
average psychotherapy provided by talk therapists cost $109.20 (SE=44.49, p=0.014) less than
psychotherapy provided by biomedical practitioners. Talk therapists were also found to be more
cost effective than biomedical practitioners (MD=110.54, SE=45.98, p=0.016). Whereas no
significant difference was found between the number of sessions provided by talk therapist
versus biomedical practitioners [F (1, 11,913) = 2.50, p = 0.114].
Question four also asked what differences exist between biomedical and talk therapist in
terms of the outcomes of dropout and recidivism. As shown in table 11, logistic regression was
used to compare dropout and recidivism between biomedical providers and talk therapists.
Biomedical practitioners were used as the reference group. Individuals who received services
from talk therapists were less likely to dropout compared to those who received services from
biomedical practitioners (B= -.520, SE = .119, p < .001). These results indicate that individuals
who received services from Biomedical practitioners were 68 times more likely to drop out
23

Running head: Cost-effectiveness of Treating Post-Traumatic Stress Disorder
compared to those who received services from talk therapists practitioners (exp[-.520] = .594).
No difference was found in recidivism rates between talk therapists and biomedical practitioners
(B=-.193, SE = .120, p =.108).
Question five asked “What are the differences in treatment outcomes (cost effectiveness,
total cost, number of sessions, recidivism, and dropout) when comparing treatments provided by
Masters level practitioners compared with doctorate level practitioners?” The statistical test
ANCOVA was used to compare the treatment outcomes of total cost, total number of sessions
and cost effectiveness. As shown in Table 9 no significant differences were found for any of the
treatment cost outcome variables: Total Cost [F (1, 12,430) = 0.072, p=.789], Total Sessions [F
(1, 12,430) = 0.117, p=0.733], Cost Effectiveness [F (1, 12,430) = 0.073, p=.0787].
Logistic regression was also used to compare dropout and recidivism between Masters
and Doctorate level practitioners. As demonstrated in Table 11, no difference was found in
dropout rates between talk therapists and biomedical practitioners (B=.031, SE = .045, p
=.488).No difference was found in recidivism rates between talk therapists and biomedical
practitioners (B=-.054, SE = .042, p =.198).
Question six asked “What are the differences in outcomes in PTSD treatment by
gender?” A one way ANOVA was conducted which found significant differences between
genders. As seen in Table 10 significant differences were found for total dollars [F (1, 12824) =
8.256, P=0.004], total sessions [F (1, 12824) = 17.239, P<0.001], and for level of cost
effectiveness [F (1, 12824) = 8.501, P=0.004]. The treatment of men with PTSD used less
sessions, cost less and was more cost effective than the treatment of women. Logistic regression
was also used to compare men and women in terms of dropout likelihood and recidivism
likelihood (See Table 11). Logistic regression was also used to compare dropout and recidivism
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between genders. Women were less likely to dropout than men (B=-.192, SE = .049, p < .001).
These results indicate that men are 21 times more likely than women to drop out of therapy
(exp[-.192] = .825) No difference was found in recidivism rates between men and women (B=0.089, SE = .047, p =.059).
Discussion
The results of this study yielded significant and impactful findings. Particularly in terms
of the impacts of treatment modality, practitioner license, practitioner degree type, practitioner
degree level, and client gender on cost effective treatment outcomes. Furthermore, these results
lay a valuable foundation for future research and provides meaningful implications for the field
of psychotherapy.
Therapy modality was found to have significant impacts on the treatment outcomes of
total cost, total sessions, cost effectiveness, dropout likelihood and recidivism likelihood. As
reported by Crane and Payne (2011), in general, family therapy is more cost effective than
individual therapy or a mixed modality of therapy. The findings of this study are consistent with
the previous findings in that family therapy was found to have fewer sessions on average, fewer
total cost in the first episode of treatment and a more cost effective level of treatment expense.
When treatment outcomes were compared by modality using a Tukey Post hoc test, as shown in
table 2 it was found that family therapy had the lowest average total cost $295.32 (SD=441.70),
while individual therapy had the second lowest average $538.99 (SD=841.88), followed by a
mixed modality of therapy which had an average cost of $918.59 (SD=1,181.00). The total
number of sessions during the first episode of care followed a similar pattern. A Tukey Post hoc
test also revealed that the mean number of sessions for family therapy was 5.89 (SD=7.05), while
individual therapy had an average number of sessions of 10.74 (SD=14.94) and mixed therapy
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had an average number of sessions of 18.41 (SD=18.53). When the first episode of care costeffectiveness was analyzed using a Tukey Post hoc test family therapy had an average of 302.38
(SD= 866.31), while individual therapy had an average of 554.94 (SD=866.32) and mixed
modality cost effectiveness average was 949.34 (SD=1212.65).
One theory for the cost effective results for treating PTSD with a family therapy modality
is the impact that increased social support has on trauma symptoms. Increased social support is
shown to have a moderating influence on PTSD symptoms (Elhers et al., 2013). Brewin et al.,
(2000) reported similar findings, claiming that lack of social support was the largest risk factor
they found for those with continued symptoms of PTSD. Greenman and Johnson’s 2012 study
supports this as they reported significant reductions in PTSD symptoms in trauma victims after
providing emotionally focused couples therapy to victims and their partners.
Furthermore, recidivism and dropout were also compared across treatment modalities.
As displayed in Table 3 It was found that, individuals who received individual therapy were 203
times as likely to return for a second episode of care and those who received mixed therapy were
749 times as likely to return for a second episode of care. This could be for a variety of reasons.
Family therapy may not have worked for the client so they decided to not try family therapy
again if they needed further services. Also it may be that family therapy is harder to schedule
due to the need to coordinate schedules across multiple members of the family. It may also be
that individual and mixed therapy was more comfortable and so they decided to return for a
second episode of care within the same modality. It may simply be that family therapy was
better at long term reduction of symptoms and so symptoms returned for those in the individual
or mixed modalities. Finally it may be that family members learned how to help the client
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manage their symptoms and thus the client no longer needed a therapist to help them heal from
their trauma.
Practitioner licensure was also found to have a few significant impacts on PTSD
treatment outcomes. Treatment outcomes were compared between the six practitioner licenses
types within this study (MFTs, RNs, MDs, LPCs, and MSWs) and then also compared between
biomedical practitioners and talk therapists. It was believed that differences would be found
between the various practitioner licenses, however the main significant differences in treatment
outcomes were found between Medical Doctors and all other licenses. See tables 5, 6, and 7 for
licensure pairwise comparison results. In the end MDs used less sessions, and fewer dollars
(when controlling for fee per session) and were more cost effective (when controlling for fee per
session) than all other practitioner licenses treating PTSD. However, MDs were 156 times more
likely than MFTs to experience client dropout and equally as likely as MFTs and LPCs to
experience client recidivism. It is unclear as to the reasons for Doctors being more cost effective
than all other practitioners but it may be that they see clients for just 1 session and refer or
prescribe medication to manage trauma symptoms. It may also be that Doctor’s preferred
modality includes 1 session of treatment with long gaps between each treatment. This would
help explain doctor’s higher statistical propensity for client drop out. But, if this were the case,
then this higher statistical drop out would only be a reflection of the operational definition of
drop out within in this study. The other important finding that should not be over looked is the
fact that in general talk therapists were found to be statistically equal, when controlling for fee
per session, in terms of the treatment outcomes of total sessions, total cost, drop out, and cost
effectiveness (See Tables 4, 5, 6, 7 and 8). These are important findings because they show that
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talk therapists regardless of licensure yield essentially the same results (when controlling for fee
per session).
Furthermore, when the practitioners were divided into talk therapists and biomedical
practitioners more significant results were found. As demonstrated in Table 9, on average
psychotherapy provided by talk therapists cost $109.20 (SE=44.49, p=.014) less than
psychotherapy provided by biomedical practitioners. Talk therapist were also found to be more
cost effective than biomedical practitioners (MD=110.54, SE=45.98, p=.016).
Although, similar numbers of men and women are exposed to trauma events, it has been
reported that women are two times as likely to develop PTSD (Tolin & Foa, 2002). Results from
this data set had an even high gender disparity with more than three times as many women
(9,823) as men (3,000) diagnosed with PTSD. The results demonstrated in Table 10 revealed
that on average women received more sessions of care and that care cost more over all.
Furthermore, men were found to be more cost effective to treat than women. These results show
that not only are more women traumatized than men, but also that they spend more time in
treatment and that they spend more dollars on treatment. These key findings help present the
ways in which PTSD treatments may be impacted by gender and vice versa.
Limitations
The current study employed retrospective comparative outcome analysis of
administrative data. Due to the limitation of the variables that were available within the data, the
cost effectiveness analysis conducted was not the “gold standard” of cost effectiveness research
(Pirraglia, Rosen, Hermann, Olchanski, & Neumann, 2004). The lack of using an experimental
design may produce potential biases within the results. For example, clients may have been
influenced by outside factors to select a specific treatment provider. Treatment modality was
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also not randomly assigned and clients may have self-selected into or out of specific modalities.
It may be that cases in which more symptoms were manifested lead to a use of a mixed modality
because of attempts to involve outside influences. Therefore, the lack of random modality
assignment may be a limitation to the research. On the other hand, there are many benefits to
gain from this study being done in real life, as opposed to within the constrictions of an
experiment. Furthermore, not all practitioners receive the same level of training even within the
specific practices, as such that may impact the results of this study (Moore, et al., 2011). Also it
is a limitation to think that cost effective treatments are the most effective treatments. This
would be an unwise assumption to make because it may place greater importance on the costs
than one would place on patient needs. However, when balanced together cost effectiveness and
treatment effectiveness can be united to provide all around benefits.
Another potential limitation would be measuring treatment outcomes based upon dropout
and recidivism. These are not the best measures of success, but they were the measures that
were available. Specifically the dropout definition is a limitation to the study because dropout
for individual and family therapy are defined as not returning after the first session, whereas
dropout for the mixed modality inherently means they had to attend at least two total sessions
(one family and one individual) before they could actually drop out of therapy. Therefore, this
mixed modality dropout definition may significantly impact the cross comparison dropout
statistics. Since there are different definitions of dropout based upon modality, the results may
not be generalizable.
Furthermore, this data had a large range within the variables of total cost, total sessions,
and cost effectiveness which resulted in the standard deviations being greater than the means for
many of the statistical outputs. Such results could be negated by using a log transformation for
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calculating the inferential statistics. In spite of much debate, it was decided to leave the
statistical outputs in their original units of dollars, sessions, etc., which makes them more
readable and more easily interpreted by all audiences. As such, it is then important to note that
there is a large range within this data which leads to the size of the standard deviation being
greater than the average for many of the statistical outputs.
Directions for Future Research
Future research should be able to build significantly on this foundational study. It would
be able to use randomized control experimental designs to assess further for the impact that any
self-selection biases may have presented here. Moreover, they could analyze the ways in which
the reduction of the many biopsychosocial symptoms may impact the client’s wellbeing in other
areas of life.
It would also be valuable for future research to explore further the differences in
treatment methods between practitioners and with practitioner groups. This could provide
valuable information that would help increase understanding as to what are cost effective
treatments that help provide symptom relief and healing for those diagnosed with PTSD.
Implications
This study demonstrates the value of analyzing treatment modality and treatment
practitioners to recognize their impact on treatment outcomes. In particular the results that
family therapy modality is most cost effective for treating PTSD demonstrates the importance of
ensuring that all practitioners are trained in family therapy practices in order to be able to provide
the most cost effective treatments. Furthermore policymakers, insurance companies, and
psychotherapists would find value in the results of this cost effectiveness research as it would
better inform them as to how to allocate their resources of time, energy and money in terms of
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treating PTSD. Finally, this study supports previous studies (Elhers et al., 2013; Matsakis, 2013)
that suggested that family and social support help provide PTSD symptom reduction. As
reported in the Meta analysis conducted by Brewin, Andrews & Valentine (2000) the largest of
any of the risk factors for PTSD was a correlation with the lack of social support. Furthermore,
recent research has shown that couples treatment that takes uses emotionally focused therapy,
which strengthens the individual’s social support, has resulted in a reduction of PTSD symptoms
Therefore, the results of this study which demonstrate that family therapy is more cost effective,
utilizes fewer sessions, and costs less over all supports the results of these preliminary studies.
With family therapy utilizing the fewest number of sessions and providing the most cost
effective results it would be valuable for individuals suffering from PTSD to be informed of the
influence their family or other social support systems can have on their treatment. This could
help inform trauma victims and their families that they can find joint healing in the process of
overcoming PTSD.
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Table 1 Descriptive Statistics for PTSD in Adults
Category

N

Mean

SD

%

Total Sessions

12845

11.38

15.38

-

Total Dollars

12845

$570.92

883.89

-

Cost Effectiveness

12845

588.15

909.13

-

Recidivism

3557

-

-

28

Dropout

2887

-

-

23
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Table 2 Treatment Modality Results
M Sessions

M Cost $

M Cost

Recidivism

Dropout

(SD)

Effectiveness (SD)

%

%

Modality

N

(SD)

Individual

10804

10.74 (14.95)1*

538.99 (841.88)2*

554.94 (866.32)3*

26

24

Family

585

5.89 (7.05)1*

295. 33 (441.70)2*

302.38 (450.90)3*

10

36

Mixed

1456

18.41 (18.534)1*

918.60 (1181.93)2*

588.15 (909.13)3*

49

4

Notes. *p<0.05; 1[F (2, 12842) = 205.09, p< 0.001]; 2[F (2, 12842) = 151.60, p< 0.001]; 3[F (2, 12842) =
154.63, p< 0.001]

42

Running head: Cost-effectiveness of Treating Post-Traumatic Stress Disorder

Table 3 Recidivism and Dropout Logistic Regression by Modality as Compared to Family
Therapy
Recidivism

Dropout

Modality

B

SE B

Individual

1.11

0.14

Mixed

2.14

0.15

B

SE B

3.03*

-0.56

0.08

0.57*

8.49*

-2.68

0.16

0.07*

Notes. *p<0.05
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Table 4 Treatment Modality Outcomes
M Cost

Recidivism

Dropout

n

M Sessions(SD)

M Cost $ (SE)

Effectiveness (SE)

%

%

LPCs

2748

10.62 (0.29)1 *

527.37 (15.24)2 *

559.02 (16.90) 3*

26

24

MDs

173

7.69 (1.16) 1*

289.76 (60.79) 2*

283.38 (67.51) 3*

27

42

RNs

159

12.33 (1.19) 1*

610.89 (62.54)2 *

628.65 (68.63) 3*

36

22

MSWs

4620

11.60 (0.22) 1*

568.98 (11.68) 2*

601.22 (13.04) 3*

28

21

MFTs

987

10.93 (0.48) 1*

544.29 (25.05)2 *

573.16 (27.92) 3*

24

24

PSYs

3229

11.37 (0.27)1*

557.29 (14.26) 2*

576.00 (15.74) 3*

28

28

Profession

Notes. *p<0.05; 1[F (5, 11909) = 3.68, p= 0.003]; 2[F (5, 11909) = 4.97, p < 0.001]; 3[F (5, 11909) = 7.74, p < 0.001];
Covariates appearing in the model are evaluated at the following value: Average fee per session = 48.04
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Table 5 Total Cost Comparison between Professions in the First EoC for Adult PTSD
Profession

n

I$
-

I

LPCs

2,748

II

MDs

173

III

RNs

159

IV

MSWs

V

MFTs

987

VI

PSYs

3229

II $

III $

IV $

V$

VI $

237.61***

-83.52

-41.61*

-16.92

-29.91

-

-321.13***

-279.22**

-254.53 ***

-267.53***

-

41.91

66.60

53.61

-

-24.69

11.70

-

-13.00

4,620

Notes. * p < .05, ** p < .01, *** p < .001; Use Roman numeral assigned to each profession
for comparing between each of the professions.

-

Running head: Cost-effectiveness of Treating Post-Traumatic Stress Disorder

46

Table 6 Total Number of Sessions comparison between Professions in the First EoC for Adult
PTSD
Profession

n

I

I

LPCs

2,748 -

II

MDs

173

III

RNs

159

IV

MSWs

V

MFTs

987

VI

PSYs

3229

4,620

II

III

IV

V

VI

2.94*

-1.70

-.97**

-.31

-.74

-

-4.64**

-3.91**

-3.25 *

-3.98**

-

.73

1.40

.96

-

-.67

.23

-

-.43
-

Notes. *p < .05, **p < .01, ***p < .001; Use Roman numeral assigned to each profession for
comparing between each of the professions.
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Table 7 Cost Effectiveness Difference Comparison between Professions in the First EoC for
Adult PTSD
Profession

n

I

II

I

Counselors

2,748

-

241.34***

II

MDs

173

III

RNs

159

IV

MSWs

V

MFTs

987

VI

PSYs

3229

-

4,620

III

IV

V

-87.30

-43.46*

-17.16

- 31.42

-328.64***

-284.80***

-258.50 ***

-272.76***

43.85

70.14

55.89

-

26.30

12.04

-

-14.26

-

Notes. *p < .05, **p < .01, ***p < .001; Use Roman numeral assigned to each profession for
comparing between each of the professions.

VI

-
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Table 8 Dropout and Recidivism Logistic Regression by Practitioner License as Compared to Marriage and Family Therapists
Recidivism
Practitioner License

LPC
MD
Nurse
MSW
PSYs
Notes. *p<0.05

Dropout

B

SE B

B

SE B

0.12

0.09

1.13

-0.03

0.09

1.13

0.19

0.19

1.21

-0.23

0.09

2.56 *

0.60

0.18

1.82*

-0.01

0.21

1.00

0.25

0.08

1.29*

-0.02

0.09

0.98

0.25

0.09

1.29*

-0.33

0.09

0.97
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Table 9 Talk Therapy Vs. Biomedical

Education
Talk Therapy
Biomedical

M Cost

Recidivism

Dropout

n

M Sessions(SD)

M Cost $ (SD)

Effectiveness (SD)

%

%

11584

11.22 (15.00)1

547.65 (809.70)2

564.61 (835.243

274

225*

332

10.81 (15.13)1

656.38 (891.37)2

673.69 (917.30)3

314

325*

Notes. *p<0.05; 1[F (1, 11913) = 2.50, p = 0.114]; 2[F (1, 11913) = 6.03, p= 0.014]; 3[F (1, 11913) = 5.79, p = 0.016];
4[F

(1, 11914) = 2.586, p = 0.108]; 5[F (1, 11914) = 19.469, p < 0.001]; Covariates appearing in the model are evaluated at the following value:

Average fee per session = 48.04
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Table 10 Education Level
M Cost Effectiveness

Recidivism

Dropout

n

M Sessions(SD)

M Cost $ (SD)

(SD)

%

%

Masters

8045

10.99 (14.63)1

504. 06 (743.30)2

520.60 (767.89)3

274

225

Doctorate

4388

11.74 (16.30)1

661.52 (1045.69)2

679.33 (1072.06)3

284

225

Education

Notes. Non-Significant; 1[F (1, 12430) = 0.12, p= 0.733]; 2[F (1, 12430) = 0.07, p= 0.789]; 3[F (1, 12430) = 0.07, p= 0.787];
4[F

(1, 12431) = 1.66, p=0.198]; 5[F (1, 12431) = 0.48, p= 0.488]; Covariates appearing in the model are evaluated at the following value: Average

fee per session = 48.04

Running head: Cost-effectiveness of Treating Post-Traumatic Stress Disorder

51

Table 11 Gender Comparison
M Cost

Recidivism

Dropout

n

M Sessions(SD)

M Cost $ (SD)

Effectiveness (SD)

%

%

Female

9826

11.70 (15.79)1*

583.56 (904.93)2*

601.34 (930.98)3*

284

225*

Male

3000

10.37 (13.92)1*

530.58 (811.84)2*

546.04 (834.18)3*

264

255*

Education

Notes. *p<0.05; 1[F (1, 12824) = 17.24, p< 0.001]; 2[F (1, 12824) = 8.26, p= 0.004]; 3[F (1, 12824) = 8.50, p= 0.004];
4[F

(1, 12431) = 1.66, p=0.198]; 5[F (1, 12431) = 0.48, p= 0.488]
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Table 12 Pairwise Logistic Regression for Dropout and Recidivism
Recidivism
B

SE B

Biomedical Practitioners

-0.193

0.120

Masters vs. Doctoral

0.054

Gender (F=0 M=1)

-0.089

Dropout
B

SE B

0.825

-0.520

.119

0.594*

0.042

1.056

-0.031

0.045

0.969

0.047

0.915

0.192

0.049

1.212*

Talk therapists vs.

Notes. *p<0.05
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